 "Pfizer, Wyeth hit new high ahead of amalgamation")
Shares of drug majors Pfizer and Wyeth have rallied over 6% each at Rs 2,089 and Rs 1,396, respectively on the bourses ahead of amalgamation.
Pfizer hit a high of Rs 2,120 and Wyeth touched Rs 1,410, also their respective all-time high on the National Stock Exchange (NSE).
The board of directors of Pfizer has fixed December 11, 2014 as the "Record Date" to determine the name of equity shareholders of Wyeth who shall be entitled to receive shares of the company pursuant to the amalgamation of Wyeth with the Company. The stock will turn ex-amalgamation on December 10, 2014.
In November 2013, the boards of Pfizer India and Wyeth India approved a swap ratio, which would give Wyeth shareholders seven Pfizer equity shares for every ten held.
Pfizer hit a high of Rs 2,120 and Wyeth touched Rs 1,410, also their respective all-time high on the National Stock Exchange (NSE).
The board of directors of Pfizer has fixed December 11, 2014 as the "Record Date" to determine the name of equity shareholders of Wyeth who shall be entitled to receive shares of the company pursuant to the amalgamation of Wyeth with the Company. The stock will turn ex-amalgamation on December 10, 2014.
In November 2013, the boards of Pfizer India and Wyeth India approved a swap ratio, which would give Wyeth shareholders seven Pfizer equity shares for every ten held.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%